The journey from identifying a disease target to developing a viable treatment is long and complex, heavily relying on a steady supply of high-quality chemical intermediates. (alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide (CAS: 521284-19-5) is one such critical compound, serving as a foundational element in modern drug discovery efforts, particularly within the field of diabetes research.

As a reputable supplier and manufacturer based in China, we understand the stringent requirements of the pharmaceutical industry. This intermediate, appearing as an Off-White to Pale Yellow Solid, with a molecular formula C16H16N2O4 and a molecular weight of 300.31, is vital for synthesizing targeted therapies. Its primary application lies in the creation of (aminothiazolyl)acetanilide derivatives, a class of molecules showing promise in managing diabetes.

The consistent quality and precise chemical properties of (alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide are non-negotiable for researchers and drug developers. Its physical characteristics, including a melting point between 116-119°C, are well-documented, facilitating its integration into various synthetic protocols. When companies decide to buy this intermediate, they are investing in the reliability of their research outcomes.

Furthermore, its established role as a Mirabegron intermediate solidifies its importance in the pharmaceutical supply chain. Mirabegron is a significant therapeutic agent, and the intermediates required for its production are in high demand. Our position as a leading manufacturer in China allows us to meet this demand with consistent quality and competitive pricing, supporting global drug development initiatives.

The application of (alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide extends beyond its direct use in synthesizing specific drug candidates. It also serves as a valuable tool in broader drug discovery research, enabling the exploration of novel chemical spaces and the development of new synthetic methodologies. The pursuit of more effective diabetes treatments is a continuous effort, and intermediates like this are indispensable allies in this endeavor.

In essence, (alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide exemplifies the critical role that specialized chemical intermediates play in pharmaceutical innovation. Its availability, coupled with a deep understanding of its chemical properties and applications, empowers scientists to develop next-generation therapies for challenging diseases like diabetes. Sourcing this compound from established Chinese manufacturers ensures the quality and reliability necessary for success.